Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Mar 17, 2021 2:22pm
126 Views
Post# 32817870

RE:question

RE:questionAccording to MedX's guidance they sell the SIAscopes between $2,500-$5,000 depending on volume and client. They make between $15.00-$30.00 USD per e-consult.

Take the Netherlands for an example. They indicated they do between 20-30 scans a day per screening center @$15.00 per scan. Each center is opened 312 days a year. So the sale of a device is low but the scan volume is high.The Netherlands revenue estimate per center $15x20scans per day x312days= $93,600 per scan center. This is pure SaaS revenue. I believe MedX's partners in the Netherlands currently have 7 centers up and running and they are scheduled to have 41 scanning centers by the end of 2022. So if they have 41 centers completed by 2022 then the recurring revenue to MedX would be $3,837,600 per year. This is pure SaaS revenue which is very high margin. If they complete 21 centers in 2021 then the 2021 revenue would be $1,965,600 of recurring revenue. 

Total hardware revenue $2,500 X 41 =$102,500 on the low end.

I hope this guidance helps.
<< Previous
Bullboard Posts
Next >>